Results 231 to 240 of about 1,060,750 (286)

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

open access: yesBMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim   +9 more
wiley   +1 more source

Serendipitous Discovery of Short Peptides Dimethylammonium Salt Promoting Neural Differentiation. [PDF]

open access: yesJ Pept Sci
Khan SN   +7 more
europepmc   +1 more source

Preclinical Evaluation of Labetalol for Cutaneous Melanoma Drug Repurposing: Cytotoxic Activity in A375 Cells and Mitochondria-Associated Apoptotic Signaling. [PDF]

open access: yesMedicina (Kaunas)
Dahma R   +11 more
europepmc   +1 more source

Liposomes and MTT cell viability assay: An incompatible affair

open access: yesToxicology in Vitro, 2015
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay is commonly used to evaluate the cytotoxicity potential of drugs vehicled by liposomes. However, liposome delivering drugs could produce inconsistent values of MTT absorbance.
Fabrizio Angius
exaly   +4 more sources

Cell Sensitivity Assays: The MTT Assay

open access: yes, 2011
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay is based on the conversion of MTT into formazan crystals by living cells, which determines mitochondrial activity. Since for most cell populations the total mitochondrial activity is related to the number of viable cells, this assay is broadly used to measure the in vitro ...
van Meerloo, J.   +2 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy